Michael Rocco MD, MSCE, FNKF

Michael V. Rocco, MD, MSCE, FNKF is a Professor of Medicine at Wake Forest University in Winston-Salem, North Carolina. He received his MD degree from Vanderbilt University in Nashville, Tennessee, and also served his Internal Medicine residency at Vanderbilt. He completed a nephrology fellowship at the University of Pennsylvania in Philadelphia, Pennsylvania, and received a master's degree in epidemiology at Wake Forest University. He has been on the faculty of the Wake Forest University School of Medicine since 1991 and currently holds the Vardaman M. Buckalew Jr. Chair in Nephrology. He has more than 100 manuscripts and book chapters in the areas of hemodialysis, peritoneal dialysis, nutrition, chronic renal failure, and epidemiology. He has served as the clinical center Principal Investigator at Wake Forest for several NIH trials, including the HEMO Study, the Acute Renal Failure Trial Network (ATN), the Dialysis Access Consortium (DAC), and the Frequent Hemodialysis Network (FHN). In the HEMO Study, he served as the Chair of the Nutrition committee and the Vice-Chair of the Outcomes Committee. In the FHN Trial, he is the Clinical Core Consortium PI for the Nocturnal Trial and the Chair of the Outcomes Committee. Dr. Rocco is currently the Chair of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative (KDOQI); he served as the Vice-Chair for KDOQI from 2003 - 2007 and was the vice-chair for the NKF KDOQI Hypertension Work Group.